Skip to main content
FinSpry Logo
FinSpry
VCYT logo
VCYT
(NASDAQ)
Veracyte, Inc.
$48.73-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Veracyte (VCYT) Stock Price & Financial Analysis

Veracyte Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$47.95 - $49.75
52-Week High$50.71
52-Week Low$22.61
Open$49.44
Volume1.16M
Average Volume (3M)1.14M
Market Cap4.02B
Shares Outstanding80.57M
P/E Ratio (TTM)60.64
Forward P/E29.33
Price to Sales (P/S)7.78
Price to Book (P/B)3.07
EV/EBITDA44.40
Revenue (TTM)517.14M
Net Income (TTM)66.35M
Free Cash Flow (TTM)126.10M
EPS (TTM)$0.83
Profit Margin12.83%
Operating Margin15.18%
Return on Equity (ROE)5.07%
Debt to Equity0.03
50-Day MA$37.58
200-Day MA$37.55
52-Week Change80.62%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Veracyte

What is the current stock price for VCYT?

As of the latest trading session, VCYT stock trades at $48.73. The 52-week range is $22.61–$50.71, with a day range of $47.95–$49.75.

What is the P/E ratio for VCYT?

Veracyte's trailing P/E ratio is 60.6, meaning investors pay $60.6 for every $1 of annual earnings. The forward P/E is 29.3, reflecting analyst expectations for future earnings.

Does VCYT pay dividends?

Veracyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VCYT?

Based on 4 analysts, the consensus for VCYT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VCYT?

Veracyte's market capitalization is $3.93B, classifying it as a mid-cap company..